Alexander Nowak
Stock Analyst at Craig-Hallum
(2.56)
# 2,284
Out of 4,944 analysts
45
Total ratings
41.67%
Success rate
5.21%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $7.73 | +184.61% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $157.70 | -0.44% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $7.56 | +125.02% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $27.08 | +110.49% | 6 | Sep 5, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $52.37 | -48.44% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $12.13 | +23.66% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $6.00 | +33.33% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.54 | +1,068.83% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $11.13 | +349.24% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $14 → $8 | $0.45 | +1,677.78% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $44.91 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.86 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.70 | +307.41% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $54.71 | +101.06% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $0.48 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $4.61 | +6,407.59% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $9.32 | +200.43% | 1 | Aug 31, 2020 |
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $7.73
Upside: +184.61%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $157.70
Upside: -0.44%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $7.56
Upside: +125.02%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $27.08
Upside: +110.49%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $52.37
Upside: -48.44%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $12.13
Upside: +23.66%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $6.00
Upside: +33.33%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.54
Upside: +1,068.83%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $11.13
Upside: +349.24%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $14 → $8
Current: $0.45
Upside: +1,677.78%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $44.91
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.86
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.70
Upside: +307.41%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $54.71
Upside: +101.06%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.48
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $4.61
Upside: +6,407.59%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $9.32
Upside: +200.43%